With expertise spanning more than 60 years in the global pharmaceutical and
biopharmaceutical industry, DSM can provide you with a broad menu of clinical
manufacturing services to meet your needs today, and in the future.
Whether you’re in preclinical, or ready to take your phase III product
commercial, we combine vast scientific expertise, real-world experience and
proven success in tech transfer which guarantees once we take on your project,
we deliver on your project.
Monoclonal
antibodies and fermentation capabilities lead the breadth of clinical
service offerings within the DSM organization. With a broad range of cell
lines in the biopharmaceutical manufacturing arena including, Per.C6®, CHO,
hybridoma, DSM can support your entry, or continuation in the field of
clinicals. In addition, our fermentation competencies include strain
development optimization, strain production, process development,
process-scale up and the production of secondary metabolites and recombinant
proteins. Also, ask us about our unique pluGBug® technology through which we
enable the rapid scale-up of a strain for commercial applications.
We can further your development stream through a dedicated early phase
development team centralized under the unit of
Rescom®, which stands for responsive and committed, our customers
have at their disposal a proven team that is taking projects from pre-clinical
all the way through to commercial. Comprised of 40 researchers in
state-of-the-art laboratories, Rescom drives your project through the project
pipeline, whatever stage you’re in----preclinical, or stage III; whatever
class of company you are ---- virtual or large pharma.
When it’s time to manufacture your product, our manufacturing facilities in
Groningen, The Netherlands provides complete cGMP contract manufacturing
and process development. Two separate buildings are available for these
activities. The cGMP manufacturing facility comprises about 40,000 sq.ft. of
state-of-the-art clean rooms (mammalian cell culture, microbial fermentation
and purification), quality control laboratories and utilities. The process
development building comprises about 20,000 square feet of state-of-the-art
process development laboratories and associated utilities.
And we can finish your clinical project as well. Our
DSM Pharmaceuticals, Inc. unit based in Greenville is a leader in the
field of steriles and orals and topicals custom manufacturing
services. Clinical manufacturing capabilities are at your fingertips and
extend to aseptic filling, terminal sterilization, cold storage,
lyophilization, ampoules and vials. An industry leader in this competitive
environment, DSM Pharmaceuticals Inc. can finish your clinical requests and
get it to market.
